Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Epidural during birth may boost breastfeeding and Mom-Baby bonding

NCT ID NCT07112495

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 80 women who had a vaginal delivery with epidural pain relief. Researchers wanted to see if the pain relief helped with breastfeeding success, mother-infant attachment, and reduced burnout. The goal was to understand how making birth less painful can improve the early mother-baby experience.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2024

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having a normal vaginal delivery in the delivery room, * 19 to 45 years old * To be transferred to the Puerperium service after delivery, * The baby's APGAR score is 7 and above * 37 and above weeks of gestation * No complications in the baby and mother due to childbirth * Postnatal care by the mother's side * Mother and baby sharing the same room after birth until discharge, * The mother is breastfeeding her baby, * Mother's voluntary participation in the study. Exclusion Criteria: * Separation of mother and baby for any reason while the mother is with the baby * Transfer of the baby to the NICU * Wanting to get out of the study. * Being a single parent * Those who cannot speak and write Turkish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding Burnout, Psychological Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sakarya University

    Sakarya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.